<?xml version="1.0" encoding="UTF-8"?>
<ref id="RSOB200174C47">
 <label>47</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Katz</surname>
    <given-names>U</given-names>
   </name>, 
   <name name-style="western">
    <surname>Achiron</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Sherer</surname>
    <given-names>Y</given-names>
   </name>, 
   <name name-style="western">
    <surname>Shoenfeld</surname>
    <given-names>Y</given-names>
   </name>
  </person-group>
  <year>2007</year>
  <article-title>Safety of intravenous immunoglobulin (IVIG) therapy</article-title>. 
  <source>Autoimmunity Rev.</source>
  <volume>6</volume>, 
  <fpage>257</fpage>â€“
  <lpage>259</lpage>. (
  <pub-id pub-id-type="doi">10.1016/j.autrev.2006.08.011</pub-id>)
  <pub-id pub-id-type="pmid">17317619</pub-id>
 </mixed-citation>
</ref>
